retatrutide clinical trials results Eli Lilly's Phase 3 Trial Results: 28.7% Weight Loss | Drug Discovery & Development posted on the topic retatrutide peptide | peptidesskin
Description
What makes retatrutide unique is that it interacts with three different hormone receptors that play a role in appetite and energy regulation
There have been and continue to be advances in the GLP-1 pipeline.
Triple receptor activation for maximum metabolic impact
The drug isn't the whole story
As GLP-1 medications like Ozempic become more widely used, I think we need a more complete conversation around body composition and long-term health
Does semaglutide cause heart palpitations
